DRUG STUDY :

ERGON

DRUG ORDER INDICATIONS CONTRAINDICATION SIDE EFFECT ADVERSE NURSING

S EFFECT RESPONSIBLITY

Prevention and - Hypersensitivity to  Nausea  Coron  Assess

treatment of methylergonovine or  Vomiting ary blood
Generic Name: postpartum any component of
 Abdominal artery pressure
Methylergonovi hemorrhage due the formulation.
ne Maleate pain spasm before
to uterine atony or
- Uncontrolled  Headache (rare administ
subinvolution.
Brand Name: hypertension.  Hypertensi but ration
Ergon seriou and
on
- Preeclampsia or
 Bradycardia s) monitor
eclampsia.
 Dyspnea  Myoc for
Classification: ardial hyperten
Therapeutic infarc sion
Class:
tion during
- Uterine (rare and after
Stimulant but administ
seriou ration.
-Pharmacologic
s)  Observe
Class: Ergot
 Periph for signs
Alkaloid
eral of
vascul adverse
ar effects
ische such as
Dosage: mia chest
125mcg/ tab (rare pain,
but shortnes
seriou s of
Route: Oral
s) breath,
or
Frequency: three severe
times a day (TID) abdomin
al pain.
 Monitor
uterine
contracti
ons and
 bleeding
in
postpart
um
patients.
 Inform
the
patient
about
the
potential
side
effects
and
advise
reportin
g any
unusual
sympto
ms
promptl
y.
 Instruct
the
patient
not to
breastfe
ed while
taking
methyler
gonovin
e.